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ABSTRACT
Although it is well established that inflammation contributes to cardiovascular
disease (CVD), this thesis considers the potential for dietary-induced inflammation to
also play a role in the development of depression. Even though the association between
inflammation and depression was initially proposed over 100 years ago, treatment of
depression has focused on psychopharmacological and psychotherapy. In addition to the
increases in the chronic diseases that are the leading causes of death, including CVD,
diabetes, and several forms of cancer, consumption of meat, dairy, and highly processed
foods have also increased dramatically in recent decades. The resulting Standard
American Diet (S.A.D.) is highly inflammatory and is known to play a significant role in
the etiology of CVD. In contrast, a whole food, plant-based (WFPB) diet reduces the
body’s inflammatory response. Recognizing there are many factors contributing to these
complex conditions, is it possible that a WFPB diet that has been shown to prevent, and
in some instances, reverse CVD also has the potential to play an important role in
reducing the suffering of those diagnosed with depression?
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REVIEW OF THE LITERATURE
I.

Introduction:
This thesis examines the complex relationships between cardiovascular disease

(CVD), diet, and depression. The primary goal is to consider whether the Standard
American Diet (S.A.D.), which is highly inflammatory, has the potential to contribute to
the etiology of both CVD and depression. It is well-established that drugs that promote
inflammation lower thresholds for experiencing depressive symptoms (Kohler et al.,
2016; Rosenblat et al., 2014). Is it possible that adopting a whole food, plant-based diet
(WFPB) that has been shown to prevent and reverse CVD may also play a role in
reducing symptoms and the development of depression? The Standard American Diet
pattern, often referred to as S.A.D., is taking a devastating toll. The typical American diet
contributes to many chronic illnesses that are the leading causes of death in the United
States. Research has consistently demonstrated that reducing or eliminating refined,
processed, and animal-based foods, including meat, dairy products, eggs, bleached flour,
refined sugar, and oil, can prevent, and in some instances, reverse several serious diseases
(Esselstyn, 2008; Esselstyn et al., 2014; Ornish et al., 1990; Tuso et al., 2013). Chronic
diseases, including obesity, diabetes, CVD, cancer, and serious psychiatric illnesses,
including depression, pose a significant quality of life and financial burdens for society.
Although typically categorized apart from those “physical” illnesses, psychiatric illness
cost Americans $193 billion in lost earnings (Roehrig, 2016). Is it possible that
comparatively inexpensive behavioral interventions targeting diet and nutrition could
help reduce the prevalence of individuals experiencing both CVD and depression? Could
addressing the role of diet be part of what British Neuropsychiatrist, neuroscientist, and
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author of “The Inflamed Mind” suggests is a “radically better – way of dealing with
mental and physical health disorders together, rather than apart, as we currently do?”
(Bullmore, 2018).

II.

Depression: A Serious Mental Illness

A. Etiology & Symptoms
Major depressive disorder (MDD) is considered “major” for a reason. It is a
serious and chronic mental illness associated with significant functional impairment and
reduced quality of life (Hashmi et al., 2013; Otte et al., 2016). In addition to disrupting
mood, MDD alters cognitive processes and a variety of behavioral patterns. A diagnosis
of MDD requires meeting several criteria established by the Diagnostic and Statistical
Manual of Mental Disorders, 5th edition (APA, 2013). MDD is characterized by one or
more depressive episodes, occurring for at least two weeks of depressed mood or loss of
interest accompanied by at least five of the following symptoms: feelings of prolonged
sadness, hopelessness, loss of interest or pleasure (anhedonia), insomnia or hypersomnia,
significant weight loss or weight gain, changes in cognition, vegetative symptoms, and
psychomotor retardation (APA, 2013). Since MDD impacts mood, thought processes, and
motor functions, depressed individuals struggle to function at school, at work, and at
home.
MDD, more commonly known as clinical depression, is one of the most common
mental disorders, affecting approximately one in every five individuals worldwide
(Hashmi et al., 2013). The World Health Organization reports that, globally, 264 million
people live with MDD, with women nearly twice as likely as men to be diagnosed with
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this condition (Brody et al., 2018; GBD 2017 Disease and Injury Incidence and
Prevalence Collaborators, 2018; Kessler & Bedirhan Ustun, 2008). An estimated 17.3
million adults in the United States have been diagnosed with at least one major
depressive episode. This number represented 7.1% of the adult population of the United
States. As noted above, MDD impacts women disproportionately higher than men, with
8.7% rates for women compared to 5.3% for males (NIMH, 2019). Furthermore, as of
2017, an estimated 11 million U.S. adults aged eighteen or older experienced at least one
major depressive episode with severe impairment, representing approximately 4.5% of all
adults in the United States (NIMH, 2019). The prevalence rate of moderate to severe
depression rose from 23.2% to 41.1% from 2007 to 2018 (Duffy et al., 2019). The
importance of addressing this health crisis is further emphasized by recent evidence
suggesting that incidence rates of MDD have tripled across all demographic groups in the
United States. Those with serious mental illness also face exacerbation of symptoms and
other challenges brought on by the COVID-19 pandemic (Ettman et al., 2020; Hamada &
Fan, 2020).
Mood disorders, in particular MDD, are a significant source of morbidity and
mortality and contribute significantly to the overall global burden of disease (Kessler &
Bedirhan Ustun, 2008; Mykletun et al., 2007). Two metrics can help us better understand
the impact of a particular disease on the global population: disease burden and healthy
life years. The “disease burden” quantifies the amount of premature mortality or
disability due to worldwide illness, accidents, and risk factors. “Healthy life years”
measures the number of years that an individual is expected to live free of disability or
disease. The Global Burden of Disease study (1990-2020) and the World Health
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Organization projected that by 2020, MDD would be the second leading cause of healthy
years of life lost, second only to ischemic heart disease (Lopez & Murray, 1998). A more
recent study (2002-2030) projects that HIV/AIDS, unipolar depression, and ischemic
heart disease will be the leading causes of global disease burden in 2030 (Mathers &
Loncar, 2006). By 2030 MDD is projected to remain second in contributing to the loss of
healthy years of life primarily due to its frequency and impact on functioning and quality
of life.
In spite of the existing range of treatment options, MDD rates continue to rise.
Along with increases in MDD diagnoses, there has been a steady increase in the amount
of money spent on treatment in the United States, a testament to the economic burden
associated with MDD (Birnbaum et al., 2010; Hidaka, 2012; Kessler, 2012). Contributing
to the financial burden to our society is the fact that those suffering from and receiving
treatment for MDD frequently receive treatment for other comorbid conditions
(Greenberg et al., 2015).
Although Americans are spending more on healthcare, our citizens are sicker than
ever. In 2017 alone, the United States spent approximately $3.5 trillion, or 18 percent of
GDP, on health expenditures – more than twice the average among all other developed
countries (Forks over Knives, 2016). Increased spending on healthcare in general and
mental healthcare, in particular, would appear to be justified. However, healthcare
spending for both physical and mental illness in the United States has increased
significantly and now accounts for more than 17% of the United States economy,
approximately $2.4 trillion dollars (Dieleman et al., 2016). By 2013, Americans spent
$7.1 billion dollars on treatment of MDD, including individuals’ out-of-pocket costs as

INFLAMMATION DIET & DEPRESSION

Hamada 7

well as spending by both private and government insurance programs. Expenditures
include ambulatory care, inpatient care, emergency care, and nursing/group home facility
care – all these efforts targeting those living with MDD. Total expenditures for treating
MDD rank sixth behind diabetes mellitus ($101.4 billion), ischemic heart disease ($88.1
billion), and hypertension ($83.9 billion; Dieleman et al., 2016). Although we are
spending more money, the number of people suffering from MDD continues to rise, and
our understanding of the mechanisms surrounding its etiology remains unclear.
MDD is not a homogenous condition. Each person experiences MDD in their own
way, and it is likely that there are several different subtypes of this disorder. Symptoms
vary from mild to severe. In more severe cases, MDD may lead to suicidal ideation and
completed suicides. An estimated fifty percent of the world’s yearly 800,000 suicides
occur during a depressive episode, and individuals with a MDD are nearly 20 times more
likely than the general population to complete suicide (Chesney et al., 2014; Otte et al.,
2016).
For those experiencing MDD, an increased risk for suicide is not the only
concern. Those who experience MDD have an overall increased mortality risk of 50%
compared to the general population (Cuijpers et al., 2014). In short, those who experience
MDD are likely to endure other comorbid chronic conditions and die sooner than the
general population (Pratt et al., 2016; Walker et al., 2015). It is well established that those
diagnosed with MDD are at an increased risk of developing CVD, diabetes mellitus,
hypertension, obesity, cancer, Parkinson’s disease, and Alzheimer’s disease (Penninx et
al., 2013). The complex relationship between MDD and this wide range of illnesses is
poorly understood. It is not surprising that those suffering from significant medical
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challenges are at increased risk of MDD. However, a more complete understanding of the
relationship between mental and physical disorders remains unclear. For individuals with
MDD, changes in diet, reduced physical activity, disruption of sleep/wake cycles, and
increased consumption of alcohol and drugs have the potential to contribute to the
development of many chronic illnesses. In addition to how those changes in behavior and
lifestyle contribute to the relationship between MDD and what are considered “physical
illnesses,” it is also possible that MDD and a wide range of illnesses share other common
etiologic factors. Could systemic inflammation, known to contribute to the development
of a wide array of physical illnesses, also contribute to MDD? (Furman et al., 2019). It is
likely the body’s inflammatory response contributes to the etiology and experience of
both CVD and MDD.
B. Current Treatments for MDD
Treatment of MDD falls into two broad categories: psychopharmacology and
psychotherapy. Psychopharmacological therapies include antidepressant medications
such as serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and
monoamine oxidase inhibitors (MAOIs; Hashmi et al., 2013; Otte et al., 2016).
Alternatively, psychotherapies include cognitive-behavioral therapy (CBT), interpersonal
therapy (IPT), and problem-solving therapy as well as a variety of other lifestyle
interventions (dietary modification, lifestyle education programs, mindfulness-based
therapies, etc.). Success rates for antidepressant medications vary between different
medication categories and depend on the degree of severity of depressive symptoms.
While the efficacy of antidepressant medications is well established for the most severe
forms of depression, some critics suggest that drug treatment for mild to moderate
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depression is not reliably better than placebo controls (Kirsch et al., 2008). However, a
recent study examined the efficacy of 21 antidepressant medications (all targeting
serotonin or noradrenaline circuitry) and found that all medications appeared to exhibit
moderate effects compared to placebo (Cipriani et al., 2018). Given the wide range of
how those with mild to moderate depression respond to antidepressant medications,
efficacy for any given individual is difficult to predict.
Recovery rates appear to increase when CBT is used as an adjunct to
antidepressant treatment (Driessen & Hollon, 2010). Still, approximately one-third of
individuals with MDD experience refractory symptoms, characterized by recurrent,
prolonged cycles of severe, and in some cases, depressive episodes that do not remit
despite multiple treatment attempts (Hashmi et al., 2013; Otte et al., 2016). For treatmentrefractory patients who have not responded to antidepressant treatment or a combination
of antidepressants with psychotherapy, 70 to 90 percent of those patients benefit more
from electroconvulsive therapy (Mennitto, 2019; Otte et al., 2016). For many, despite
access to existing treatment options, MDD lingers (Bai et al., 2020; Rush et al., 2006).
Moreover, new evidence raises concern that suicide might be facilitated by
antidepressants in the adolescent population (Gunnell & Ashby, 2004; Healy, 2003).
Although progress has been made, existing treatments, both psychopharmacological and
psychotherapies, are not helping as much for those suffering from MDD as one would
hope. It is important to note that there are new novel approaches to treating MDD
including augmentation agents (e.g., ketamine) and repetitive transcranial magnetic
stimulation (rTMS). Although some studies show encouraging results, more research is
necessary to determine the efficacy, safety, and utility of these new treatment options
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(Chen et al., 2020; Shiroma et al., 2020). Taken together, it is clear that no single
treatment is likely to solve such a complex and varied condition as MDD.

III. Risks of Adopting the Standard American Diet (S.A.D.)
A growing body of evidence supports the conclusion that the S.A.D., or what is
referred to as the western diet, is a significant factor in the widespread increase of CVD
(Colin Campbell, 2013; Esselstyn, 2008; Naidoo, 2020). As noted earlier, MDD is a
common comorbidity for those suffering from CVD, and it is likely the western diet
contributes to the development of both CVD and MDD.
Immigrants appear to be at increased risk for several illnesses, particularly CVD
and MDD (Lesser et al., 2014). Cultural and societal pressures appear to contribute to the
increased incidence rates of MDD, which disproportionately impacts immigrant and
lower socioeconomic populations. Two-thirds of Mexican immigrants who immigrated to
the United States in the 1990s or earlier were forced to adopt a dramatically different diet
from their country of origin. Interestingly, as recently as 1994, the prevalence of obesity
among adults was only 10% in Mexico, compared to 26% in the United States.
Maintaining the lifestyle of one’s country of origin, including dietary habits, might act as
a protective buffer for immigrants (Barquera et al., 2008; Van Hook et al., 2018). Dietary
acculturation, specifically the adoption of western dietary habits, puts immigrants at risk
for many illnesses, including obesity and Type II diabetes (Lesser et al., 2014).
Immigrating at a younger age increases the risk for MDD, and surprisingly, the longer
one lives in America, the more at-risk immigrants become for experiencing MDD. Public
health officials suggest that as immigrants from non-western countries assimilate and
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adopt the health habits of their new western communities, including high-fat diets and
processed foods, along with reduced physical activity, an immigrant's health declines.
Unfortunately, most low-income countries now have access to the processed foods
Americans have been eating for several decades (Gordon, 2015).
The negative health impacts of social and cultural changes are not limited to those
immigrating to America. Many are moving from rural areas into metropolitan centers in
China, and both MDD and chronic physical illnesses, including CVD, are on the rise (Bei
et al., 2018). Chinese individuals born after 1966 are twenty times more likely than those
born before 1937 to suffer from a major depressive episode during their lifetime (Lee et
al., 2007). China’s population is aging and chronic diseases including CVD, obesity, and
liver and lung cancers are increasing in prevalence. The shift in dietary pattern in China
from the traditional, primarily plant-based diet and adopting increasing amounts of foods
found in the western diet appears to have played a significant role in the changing health
status in this country (Colin Campbell, 2013; Colin Campbell, 2006; Pan et al., 2012;
Thomas et al., 2020). As a result, China has seen an epidemiological shift in morbidity
and mortality from diet-related diseases. Additionally, the incidence rates of many mental
disorders, including MDD, have increased significantly over the last 30 years (Huang et
al., 2019). Although the focus of this thesis is on diet, it is important to note that many
other factors (e.g., reduced physical activity levels) associated with adopting modern
western culture can contribute, in complex ways, to the increasing number of people
experiencing MDD throughout the world.
Although MDD occurs in many forms, it tends to fall into two broad categories:
early-onset (before age 30) and late-onset (after age 35). Those diagnosed with MDD
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after age 35 have a high probability of having relatives who have CVD (Kendler et al.,
2009). Over time, the S.A.D. contributes to the development of plaque in our arteries in
response to inflammation that is the key component of CVD. The fact that those
diagnosed with MDD later in life are likely to come from families that also suffer from
CVD raises the question; how might diet contribute to the development of both illnesses?
A. The Complex Relationship Between CVD and MDD
Individuals suffering from MDD have an increased risk of CVD. In some cases,
MDD significantly worsens prognosis for recovering from CVD (Lauzon et al., 2003;
Stewart et al., 2014). Individuals with MDD that are also diagnosed with CVD have a one
to three-fold increased risk for additional cardiac events within two years (Barth et al.,
2004; Meijer et al., 2013; Meijer et al., 2011; Nicholson et al., 2006). Conversely, having
a history of CVD is associated with increased risk of MDD. Several meta-analyses
indicate a strong positive correlation between CVD and MDD (Nicholson et al., 2006;
Rugulies, 2002; Ski et al., 2016; Van der Kooy et al., 2007). Most importantly for the
current discussion, MDD and CVD are both linked to several dietary-related risk factors
including diets rich in calorically dense foods, obesity, and diabetes (Frasure-Smith &
Lespérance, 2010; Skala et al., 2006). Many researchers have suggested that the
association between MDD and inflammatory markers is a critical biochemical link in the
comorbidity of MDD and CVD (Goldston & Baillie, 2008; Joynt et al., 2003; Lippi et al.,
2009; Paz-Filho et al., 2010; Raison et al., 2006). These findings further support the need
for a more holistic approach to MDD that includes treating both the body and the mind.
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B. Mental and Physical Illness: A False Dichotomy
How have mental and physical illness come to be viewed as separate entities? The
17th century French Philosopher René Descartes’s dualistic approach separated the
physical body and non-physical or spiritual mind. As a result, western medicine typically
separates illness into either impairment of physical or mental dimensions. Put simply, the
Cartesian dualistic perspective describes two domains of our experiences. The first
domain is the outer, physical world, in which objects interact with each other
mechanistically. For example, simple spinal cord reflexes represent physical responses to
external stimuli. The second domain is the inner, spiritual world, in which emotions form
our thoughts and sense of self (Gendle, 2016). Cartesian dualism, therefore, separates the
objective physical body from the spiritual and subjective mental realm. When discussing
symptoms of most illnesses, it is common for people to ask: “Is the problem physical or
psychological/mental?” When someone with a serious physical illness becomes
depressed, the depression is most often interpreted as a psychological reaction to the
knowledge and experience of being physically ill. As noted earlier, MDD is common for
those with CVD, with the prevalence of MDD among cardiac patients ranging from
twenty to thirty percent (Thombs et al., 2006). Although they frequently occur together,
“Cartesian medicine” has promoted the belief that the mental and physical illnesses
develop independently. It is possible that in addition to the psychological reaction to
experiencing physical illness contributing to MDD, these “mental” and “physical”
illnesses share common causal factors related to diet and inflammation (Bullmore, 2018).
In a way it is strange to assume that problems in our body, in this case the
cardiovascular system, occur independent of the mental experience of MDD. Separating
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the physical and mental domains makes it less likely to consider the individual as a
whole, and a consideration of the possibility that both the physical and mental disorders
share common causal factors. Edward Bullmore describes the dualist approach in western
medicine as synonymous to “medical apartheid.” We should consider novel treatments
that target and move towards understanding the body and mind as one. The emphasis of
this thesis is to consider the potential for dietary related inflammation to connect and
influence both the mind and the body.

IV. Inflammation and Depression
A. Did Depression Evolve as Part of the Inflammatory Response?
The evolutionary theory of MDD suggests that MDD evolved as an advantageous
response to inflammation and infection (Anders et al., 2013). Depressive behavior may
have been an adaptive response to help individuals as they fight off, and attempt to
survive, infection or injury. The infection-defense hypothesis considers MDD as a
beneficial “sickness-like” behavior that includes social withdrawal, anhedonia, fatigue,
hypersomnia, and psychomotor retardation. The symptoms and behaviors observed in
MDD, such as anorexia, weight loss, decreased locomotor activity and exploration,
fatigue, sleepiness, and inability to concentrate, are also seen in sickness behavior.
Withdrawing from contact with others reduces the risk of infection or transmitting
infectious diseases to other genetically related individuals. Self-isolating behavior, which
is common in both depression and sickness behavior, also allows one to conserve energy
and promotes restfulness to help the individual have a better chance of fighting off the
infection and enhancing recovery (Maes et al., 2012). Reduced activity helps recovery by
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conserving energy while dealing with the inflammatory response. Put simply, when we
become infected and our immune system responds by releasing pro-inflammatory
cytokines, we feel lousy, sick, weak, and fatigued. In essence, we act as though we are
depressed when we are ill (Anders et al., 2013). An important distinction between
sickness behavior and depressive symptoms is that sickness behavior is an acute, shortterm state in response to an acute inflammatory response, whereas depressive behavior
may be the result of more chronic, long-term accumulation of inflammation in the body
that has gone unnoticed (Maes et al., 2012).
If the association between inflammation and MDD evolved because the
depressive response to inflammation was advantageous, then we should expect to see that
the genes for an increased risk of MDD are related to individual differences in one’s
immune system. It is well-established that MDD runs in families; people whose parents
were diagnosed with MDD are three times more likely to suffer from MDD than those
who do not have a parent with MDD (Dunn et al., 2015; Sullivan et al., 2000). However,
families share more than genes. It is likely that children learn how to become depressed
from living with a depressed parent (Loechner et al., 2020; Rishel, 2012). Also, research
linking specific genetic profiles to MDD is inconclusive. A recent study attempting to
provide a genetic map for MDD suggests that the human genome includes at least fortyfour “genes for depression,” including several genes that play a role in the immune
system (Wray et al., 2018). Although additional studies are needed, these findings
support the suggestion that inflammation may be one of many underlying factors
contributing to MDD and further emphasize the importance of holistic treatment of both
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mental and physical disorders. We should consider the bigger picture including our
current lifestyle, the western diet.
B. The Inflammatory Response
Inflammation is a natural part of the body’s immune response to infection by a
pathogen (i.e., a bacteria or virus), or tissue damage (i.e., physical injury; Chen et al.,
2018). Inflammation can occur as an acute and short-lived response or be part of a longlasting, chronic condition. An acute inflammatory condition occurs in response to a
pathogen or injury. In this case, when the pathogen is no longer present or the injury is
resolved, the inflammatory response ends. However, when the inflammatory response is
prolonged, the response is systemic, meaning inflammation occurs throughout the body.
As a result, chronic inflammation has the potential to contribute to a wide array of
chronic or systemic illnesses, including CVD (Zhong & Shi, 2019).
The acute inflammatory response is familiar to anyone who has suffered either a
minor or severe injury. Both a paper cut and a major strain result in inflamed, red, and
painful tissues – all part of the body’s healing process. The five signs of inflammation
were first identified by Celsus in Roman times: redness (rubor), swelling (tumour), heat
(calor), pain (dolor), and loss of functions (functio laesa; Bullmore, 2018). In response to
infection our immune system releases white blood cells into the bloodstream and tissues
to protect the body from foreign invaders. The inflammatory response increases blood
flow to the area affected by injury or infection causing redness and warmth. Chemicals
released from our white blood cells cause fluid to leak into tissues, resulting in the
familiar sign of swelling or inflammation (Punchard et al., 2004). If it were not for our
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body’s inflammatory response, we would be left defenseless against infectious diseases,
tissue damage, or physical injury.
Although we benefit from acute inflammation, we now know that chronic
inflammation plays a role in many chronic illnesses (Furman et al., 2019). Chronic
inflammation is associated with gut dysbiosis (leaky gut syndrome), CVD, obesity,
metabolic syndrome, diabetes mellitus, and several types of cancer. Symptoms of chronic
inflammation differ from the symptoms of acute inflammation and include fatigue, fever,
rashes, abdominal pain, and chest pain. Although one can easily understand and visualize
an acute inflammatory response, the long-term chronic inflammatory response is more
difficult to appreciate and address.
Medical conditions associated with chronic inflammation can be considered
within two categories; those which are directly related to diet and those that are
considered outside the role of diet and digestion. Obesity is first on the list for conditions
associated with dietary-related inflammation. Excess adipose tissue releases
inflammatory mediators and as a result, obese individuals exist in a chronic state of
systemic inflammation (Calder et al., 2011). A second dietary condition related to the
inflammatory response is microbiome-dysbiosis, or the disruption of the microbiome in
the gut. Leakage of bacteria from the intestinal tract directly into the bloodstream
activates immune cells and contributes to a pattern of chronic inflammation. It may be
possible that chronic inflammation associated with obesity and leaky gut may contribute
to the etiology of depressive symptoms. Could adopting a less inflammatory diet reduce
the risk for developing MDD?
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Consumption of vegetables, fruits, whole grains, and legumes have been shown to
reduce inflammatory biomarkers including Interleukin 6 (IL-6) and C-reactive proteins
(CRP; Lopez-Garcia et al., 2004). In contrast, consumption of large amounts of red meat
and processed-refined foods elevate levels of inflammatory markers (Lopez-Garcia et al.,
2004). Consumption of large amounts of animal products and heavily processed foods is
associated with higher levels of CRP, while the Mediterranean diet that emphasizes
whole foods and fruits and vegetables is associated with lower inflammatory markers
(Fung et al., 2001). Much of the S.A.D. is inflammatory and, as a consequence, has the
potential to impair the immune system (Myles, 2014). Examples of pro-inflammatory
foods include fried and highly refined and processed foods containing added sugars that
elevate CRP. Sucrose-rich processed foods consistently increase inflammatory
biomarkers (Jenkins et al., 2003). In contrast, whole grains such as millet, quinoa, and
barely, with a low glycemic index appear to promote healthy immune function,
established by measuring changes in intestinal microbiota as microbial changes in the gut
have often been associated with inflammatory status in the body (Parikh et al., 2012;
Tachon et al., 2013; Volman et al., 2008).
In addition to highly processed and sugary foods that elevate blood glucose levels
and increase biomarkers for inflammation, much of the S.A.D. contains large amounts of
inflammatory fats and oils. Processed and fried foods containing omega-6 fatty acids and
trans-fatty acids increase the production of pro-inflammatory cytokines and as a result
promote inflammation (Rangel-Huerta et al., 2012; Simopoulos & Cleland, 2003).
Dietary interventions show inflammatory biomarkers can be reduced by simply changing
what we eat. Participants randomly assigned to a diet rich in fruits and vegetables (eight
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servings a day) for eight weeks had significantly lower CRP levels than those who
consumed two or less servings a day (Watzl et al., 2005).
Apart from those dietary and digestive conditions long term chronic inflammation
occurs with the following conditions: chronic stress, untreated infections or injuries,
autoimmune diseases in which the immune system attacks healthy tissue, Hepatitis (i.e.,
inflammation of the liver), and a wide array of medical interventions including surgeries,
radiation, and chemotherapy. It is not surprising that MDD is also more likely for those
suffering from all those conditions in which chronic inflammation occurs.
C. Inflammation Triggers Both Physical and Depressive Symptoms
Fortunately, in recent years, questions bridging the gap between the field of
psychiatry and diet-related immunology (immuno-psychiatry) are now being asked:
“How can inflammatory changes in the body affect our mood, cognition, and behavior?”
“How can our immune system, which is built to help protect us, make us depressed?”
(Dantzer et al., 2008; Maes, 1995; Raison et al., 2006; Smith, 1991).
Inflammation is not typically associated with changes in mood. As stated earlier,
acute inflammation is the response of the immune system to an infection or threat. White
blood cells known as macrophages attack and engulf bacteria and other infectious
pathogens. Macrophages also secrete proteins into the bloodstream known as cytokines,
which circulate throughout the body further alerting the rest of the immune system
response. Therefore, macrophages play two distinct roles: 1) deal directly with the
infection at the afflicted site and respond as necessary, and 2) amplify a signal to the rest
of the body, encouraging the release of more immune cells into the bloodstream to assist
in attacking the infection. Most importantly for the current discussion is the fact that
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cytokines act within the central nervous system to produce the psychological components
of fatigue, fever, and decreased appetite; the symptoms we are familiar with when we are
sick. It is now known that the inflammatory response impacts the central nervous system,
with the potential to influence neural circuits controlling affect and mood (Olofsson et al.,
2012).
The “coincidence” of MDD and inflammation is actually quite common.
Individuals with rheumatoid arthritis, an auto-immune and inflammatory disease, are two
to four times more likely to experience depressive symptoms (Margaretten et al., 2011).
Similar to the previous discussion of MDD occurring in response to diagnosis of heart
disease, it is not surprising that those who have been diagnosed with an auto-immune
disease, and are experiencing chronic pain, report that they are also sad and depressed. As
stated previously, in these instances it is commonly assumed that the immune system that
is responsible for the physical symptoms occurring within the body, while the symptoms
of MDD are simply the result of psychological interpretations (taking place in the brain)
of those bodily changes. Until recently, the brain and immune system were thought to be
separated by the Blood Brain Barrier (BBB), a network of cells that acts as a selective
filter. In the case of the inflammatory response, the BBB was thought to prevent
macrophages and cytokines circulating in the body from reaching the brain. Thus, the
brain was thought to be protected and separated from the inflammatory response
occurring in the body. However, discoveries in recent decades provide evidence
demonstrating inflammatory cells, as well as other proteins including CRPs cross the
blood brain barrier and act upon brain cells (e.g. microglia) which initiate an
inflammatory response within the brain itself. Not surprisingly, an increase in
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inflammatory cytokines in the blood and in the cerebrospinal fluid is predictive of an
increase in symptoms of MDD (Berk et al., 2013; Bullmore, 2018; Hashmi et al., 2013).
Following cytokine administration, healthy individuals experience somatic symptoms
such as fatigue, aches, pains, loss of appetite, and even insomnia (Rosenblat et al., 2014).
Up to 50% of those who received cytokines developed symptoms of MDD, including but
not limited to depressed mood, feelings of guilt, worthlessness, and suicidal ideation
(Rosenblat et al., 2014). Thus, the inflammation that initially occurred within the body
has the potential to impact the brain in multiple ways that may contribute to the
development of symptoms of MDD. It is worth noting that individuals with elevated
levels of these inflammatory biomarkers are less likely to respond to antidepressant
treatment particularly SSRIs (Haroon et al., 2018).
If inflammation has the potential to contribute to the experience of MDD, we
should expect inflammation to precede the onset of depressive symptoms and that
evidence exists. Inflammation early in life appears to precede depressive symptoms.
Khadaker et al. (2014) assessed biomarkers for inflammation in young individuals. Data
were collected from nine-year-olds who were not depressed, and again nine years later.
Accordingly, higher levels of the systemic inflammatory biomarkers, specifically IL-6, in
childhood were associated with an increased risk of developing MDD in young adulthood
(Khandaker et al., 2014).
It is important to stress that this thesis is not suggesting dietary changes that
reduce inflammation will solve all the problems associated with a disorder as complex as
MDD. Rather than consider MDD as an inflammatory disorder, it is more likely that
depression is a response to inflammation. Since not everyone who is depressed shows
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evidence of chronic inflammation, it is more likely that inflammation may be one of
many contributing factors that lowers the threshold for MDD in a particular subset of
individuals. Thus, while the emphasis here is on the potential role of diet-induced
inflammation, it is important to stress that many factors contribute to the onset and
development of MDD.

V. The Impact of the Standard American Diet
The S.A.D. is a major contributor to obesity, anemia, osteoporosis, Type II
diabetes, hypertension, and several forms of cancer (Jacka et al., 2010). Previous diets
that emphasized non-processed fresh foods that are high in fiber, nutrient-dense foods,
and omega-3 polyunsaturated fatty acids have been largely replaced by diets high in
saturated fats and refined sugars (Drewnowski & Popkin, 1997). In addition to the
chronic illnesses mentioned above, there is no longer any doubt that the S.A.D., high in
unhealthy fats and sugar, is a key factor in the development of atherosclerosis (i.e.,
hardening of the arteries) – the underlying mechanism of CVD. Dr. Caldwell Esselstyn,
author of, “Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven,
Nutrition-Based Cure” summarizes how the S.A.D. sets the stage for heart disease
(Esselstyn, 2008).
The typical S.A.D. elevates cholesterol, in particular low-density-lipoproteins
which are the basis for plaques forming within blood vessels. Once plaques begin to
impair blood flow, inflammatory enzymes attempt to thin or reduce the build-up of
plaque. If and when plaque is dislodged from a blood vessel, their presence in our blood
activates the release of clotting factors known as platelets, which increase risk further by
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making our blood “sticky.” Heart attacks occur when plaques block arteries that supply
the heart with oxygen and necessary nutrients it needs and begins to die. As a result of
how poorly many children now eat, recent studies demonstrate that plaque begins to
accumulate in the arteries as early as age ten, resulting in chronic inflammation (Hong,
2010). Given that atherosclerosis begins in childhood, and progresses during adolescence
and young adulthood, it is no surprise that individuals raised on the S.A.D. already have
“fatty streaks” within their arteries, the first stage of CVD (McMahan et al., 2006). Such
“fatty streaks” then turn into plaque when people are in their 20s and over the next
decade or two have the potential to form life-threatening blockage of arteries.
Fortunately, dietary changes have been shown to prevent, and even reverse, this key
pattern of CVD (Esselstyn, 2008).
It may come as a surprise to many that consuming a single meal high in animalbased saturated fat produces an inflammatory response, which significantly reduces
arterial blood flow (Erridge et al., 2007; Plotnick et al., 1997). Within hours of
consuming significant amounts of saturated fat, the arteries become nearly “paralyzed,”
cutting blood flow in half. Even if the body has a few hours to recover, if the next meal
also consists of meat, poultry, eggs, or dairy (all high in saturated fat) the result is even
more inflammation. Consequently, the bodies of many people consuming the S.A.D. are
trapped in a state of chronic, low-grade, diet-induced inflammation.
Fortunately, individuals diagnosed with CVD that adopt a WFPB diet that reduces
or eliminates most animal-based foods, show improved cardiovascular functioning,
without the use of statin drugs or surgery (Esselstyn, 2008). In the landmark Lifestyle
Heart Trial, 82% of individuals diagnosed with CVD who adhered to a WFPB dietary
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pattern had significant regression of disease after just one year, marked by 40% decrease
in lipoprotein, a precursor of plaque (Ornish et al., 1990). Is it possible for the dietary
changes that reduce the chance for and promote recovery from CVD, also be used to treat
and prevent MDD? Even though dietary induced inflammation may play a role in the
development of both CVD and MDD, it is important to recognize that inflammation is
not found in all those who experience MDD. Thus, a dietary approach is not a one-sizefits-all solution to MDD.

VI. The Whole Food, Plant-Based Diet
The WFPB diet is often confused with vegetarian and vegan diets. As defined by
Dr. T. Colin Campbell, a WFPB diet is centered on whole, unrefined, or minimally
refined plants. It is a diet based on nutrient-dense fruits, vegetables, tubers, whole grains,
and legumes; and it excludes or minimizes meat (including beef, poultry, and fish), dairy
products, eggs, and highly refined foods such as bleached flour, refined sugar, and oils
(Colin Campbell, 2013; Pulde et al., 2019). Vegetarian and vegan diets are defined on the
basis of what is not eaten rather than what is eaten. Therefore, as long as they eliminate
animal products from their diet, vegetarians and vegans are free to eat highly processed
foods. Although leaders in the field of WFPB diets have varying opinions as to what the
optimal WFPB diet is composed of, Dr. Dean Ornish recommends small amounts of
certain animal-based products such as egg whites and skim milk (Ornish et al., 1990). In
contrast, Dr. Caldwell Esselstyn recommends complete avoidance of all animal-based
foods as well as soybeans and nuts for those with severe CVD (Esselstyn, 2008). In spite
of these variations in the composition of a WFPB diet, evidence suggests that a broadly
defined plant-based diet has significant health benefits (Tuso et al., 2013).
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There are five major food groups in a WFPB diet including fruits, vegetables,
tubers, whole grains, other starches in “whole form,” and legumes (see Figure 1; Stone,
2011). There are several other types of plant-based foods one can consume such as nuts,
seeds, avocados, tofu, tempeh, whole-grain flours and breads, and plant-based milks;
however, because these foods are more calorie-dense, and can contribute to weight gain
and mild inflammation, it is recommended that these be consumed in moderation. Most
people adopting a WFPB diet are able to consume foods ad libitum, meaning they can eat
as much as they desire – no need for calorie counting or portion control. The main focus
of a WFPB diet is to improve the quality of the food one consumes, rather than restricting
the quantity of the food. This may be a more suitable intervention for those who are
suffering from MDD as compliance is a major challenge for those attempting to adopt a
new diet. Since there are less published results concerning strictly WFPB diets, this
review will incorporate findings based on what are classified as a “Mediterranean Diet”
since they emphasize plant-based, unprocessed foods.
A. Inflammation and the Whole Food, Plant-Based Diet
As previously mentioned, CRPs, a biomarker of inflammation, are elevated in
individuals suffering from MDD, as well as CVD as CRPs are indicative of inflammation
in the bloodstream. Adhering to a WFPB diet can decrease CRP levels by 30% within
just two weeks (Jenkins et al., 2003). Given that a WFPB diet is rich in fruits and
vegetables, it is associated with lower inflammatory markers due to the anti-inflammatory
properties of antioxidants (Michael Maes et al., 2011). Accordingly, recent studies have
shown that antioxidants combat neuro-inflammation caused by free radical damage,
which is thought to be a precursor to several psychiatric illnesses including MDD and
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anxiety disorders. By reducing free radicals, we reduce inflammation, and in turn,
improve symptoms of MDD (Berk et al., 2013).
Several studies have found that limiting processed and refined foods is important
in reducing one’s risk for or prevention of MDD; however, incorporating diet as part of
the treatment of MDD has yet to be elucidated. A recently published meta-analysis
provides evidence that a balanced plant-based dietary pattern (e.g., Mediterranean,
whole-food, plant-based, vegetarian, or vegan, etc.), lowers one’s risk for MDD, and
demonstrated that improvement in diet significantly reduced depressive symptoms (Firth
et al., 2019; Molendijk et al., 2018). Findings are encouraging, but to our knowledge,
there have been only two extensive randomized controlled trials (RCTs) in adults with
MDD – the SMILES (Supporting the Modification of lifestyle in Lowered Emotional
States) trial, and the HELFIMED (Healthy Eating for Life with a Mediterranean Diet)
trial (Jacka et al., 2017; Parletta et al., 2019). The results of the SMILES trial
demonstrated that individuals in the dietary intervention group, that emphasized plantbased foods, had a larger reduction in depressive symptoms over the three-month study
period when compared to those in the social support control group. By the end of the
SMILES trial, 32.3% of individuals in the dietary intervention group met criteria for
remission of MDD over twelve weeks when compared to the 8% in the social control
group.
The findings of the SMILES trial are consistent with, and further support, the
findings of the HELFIMED study, which also examined the use of diet for the treatment
of MDD. The HELFIMED trial evaluated a group-based dietary intervention
supplemented with omega-3 fish oil supplements, similar to the SMILES trial, and

INFLAMMATION DIET & DEPRESSION

Hamada 27

conducted cooking workshops for adults with self-reported depressive symptoms. The
dietary protocol of the study mirrored that of a Mediterranean-style diet that limited meat
and dairy while emphasizing fresh fruits and vegetables. Three months following the
dietary intervention, individuals in the dietary group showed significant reductions in
depressive symptoms and improved mental health outcomes when compared to a social
support control group. Surprisingly, dietary improvements were sustained at six months
following the intervention when individuals were reassessed. The adherence of depressed
individuals to dietary protocol after the study’s termination is promising as treatment
adherence is often challenging for individuals with serious mental illness, in particular
MDD (Sirey et al., 2017). Adherence to dietary advice is typically very poor even for the
general population, so the fact that individuals in the dietary intervention group were able
to adhere to diet recommendations is encouraging (Francis et al., 2019). One possible
explanation for increased dietary adherence is the fact that in plant-based nutrition,
individuals are encouraged to consume foods ad libitum. Another possible explanation is
that the Mediterranean diet is a highly palatable diet, and includes a variety of food
options, making it more likely to become a sustainable part of a healthy lifestyle (BachFaig et al., 2011; Parletta et al., 2019).
Containing significant amounts of fiber that provide satiating bulk, plant-based
foods help terminate hunger signals (Pulde et al., 2019). Put simply, the strategy of plantbased nutrition is to improve the quality of the food rather than restricting the quantity of
food because, usually, a major challenge for individuals attempting dietary restrictions.
Also, “diets compel us to fixate on restriction and portion sizes, leaving us feeling hungry
and miserable...worst of all, diets rely on “willpower,” that elusive virtue that will almost
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always crumble, right along with our self-confidence,” which further explains adherence
in the aforementioned studies; since consumption is unrestricted participants may feel
more compelled to follow-through with a dietary intervention plan (Pulde et al., 2019).
In addition to the RCTs conducted in adults, a brief dietary intervention with a
younger population of depressed individuals showed that increased consumption of plantbased foods reduced symptoms of MDD. Although this particular intervention lasted only
three weeks, participants’ dietary changes were maintained for three months following
the intervention (Francis et al., 2019). All three RCTs, the SMILES trial, the HELFIMED
trial, and brief dietary intervention for young adults had similar diet protocols, advising
individuals in the dietary intervention groups to increase consumption of vegetables,
fruits, whole grains, nuts, and seeds, and decrease consumption of highly process and
refined foods. Additional RCTs including the PREDIMED (Prevención con Dieta
Mediterránea) study which successfully implemented the Mediterranean diet in adults
with high cardiovascular risk. Most importantly for the current discussion is that in
addition to reducing the risk for CVD, the dietary intervention of the PREDIMED study
also decreased the risk of participants experiencing depressive symptoms (Zazpe et al.,
2008).
It should be noted that the dietary interventions in the studies mentioned above
included fish, fish oil supplements, and other oils like olive oil in their diet protocols.
Nevertheless, in addition to meat and dairy, consumption of fish and all oils have the
potential to contribute to chronic, systemic, low-grade inflammation since fish has as
much cholesterol as beef, poultry, and pork (Parletta et al., 2019; Pulde et al., 2019).
Therefore, although the Mediterranean diet appears to be a significant improvement from
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the S.A.D., it does contain foods that should be consumed in moderation. A WFPB diet
advises against inclusion of fish, oils, and other dietary supplements (i.e., fish oil) as
some studies have demonstrated that omega-3 found in fish is pro-inflammatory (Lucas et
al., 2014). Consumption of fish was associated with increased CRP levels; consistent
with recent findings that omega-3 fatty acids do not appear to help with improving either
MDD or inflammation and was also found to be ineffective in preventing CVD (Bloch &
Hannestad, 2012a, 2012b). Furthermore, the HELFIMED study which provided
individuals with fish oil supplements found no significant correlation between increased
omega-3 and improved depressive symptoms (Parletta et al., 2019). Therefore, adopting a
WFPB diet excluding (or limiting) intake of fish as well as single nutrient supplements
(i.e., fish oil) is likely to have far greater benefit for both CVD and MDD.
As is the case for antidepressant medications that include side effects such as
impotence, there are side-effects for adopting a WFPB diet. The side effects include loss
of excess weight, decreased risk of developing several chronic illnesses, and moving to
an ideal weight. Unlike impotency, these are side effects that you want.

VII. Conclusion and Future Directions
Obviously, our current approaches to MDD are not as effective as one would
hope, and they are not sustainable. With all the available treatment options for MDD
from new medications to psychotherapy, and all the expenses, there is escalating
mortality and morbidity. The focus of this thesis has been to consider incorporating a
dietary approach to reduce inflammation in our attempts to help those experiencing
MDD. Most significantly, diet is a malleable risk factor, making it amenable to
intervention and preventative strategies.
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Although we may not be able to cure all chronic inflammatory diseases, including
CVD and MDD, implementing primary prevention strategies such as a WFPB dietary
intervention may allow us to both manage existing symptoms and prevent exacerbation of
symptoms (Tuso et al., 2013). Given that we understand that inflammation plays a
potential role in the etiology of MDD, implementing an anti-inflammatory diet allows for
a more personalized treatment approach for individuals with MDD (Kohler et al., 2016).
There are several benefits to collaborative dietary decision-making on one of the
hallmark symptoms of MDD, hopelessness, which is encouragement of individuals to
play an active role in decisions concerning their health and mental well-being. By
encouraging involvement in making dietary changes, it provides an increased sense of
self-efficacy, an important factor that has the potential to contribute to improved affect,
independent of the nutrition changes in the body. A possible way to facilitate transition to
a WFPB diet is a shared-decision-making process (SDM). Implementing a SDM process
allows both healthcare professionals and individuals with MDD to jointly assess dietary
intervention plans, and agree on a treatment that works for both the healthcare provider
and individual (Desroches et al., 2011). This method of intervention is an ideal strategy
for encouraging adherence to dietary advice, a critical component in preventing and
managing treatment plans. Using SDM as an intervention is particularly relevant to those
with MDD as it may enhance self-efficacy, provide a sense of control, and empowerment,
allowing them to overcome helplessness and hopelessness (Raue et al., 2010). An
individual participating in their own treatment plan can also improve outcomes as small
improvements in diet quality has been associated with promoting resilience (Lutz et al.,
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2017). Making dietary changes is a challenging, yet empowering approach to early
prevention and intervention.
For those with MDD, quality of life should be a primary concern. In addition to
poor diet, individuals with serious mental illness, in particular MDD, lack an adequate
understanding of the effects of poor lifestyle behaviors on health (Parletta et al., 2019). It
is important to acknowledge that not everyone has the same opportunity to eat healthier
as financial barriers, and inadequate access to resources, remain a challenge for those
living with serious mental illness (Cheung et al., 2021). Those living in lower
socioeconomic environments, in what are referred to as “food deserts,” may not have the
opportunity and financial resources to make healthier food choices. When the only store
an individual has access to is a convenience store, they are not likely to find fresh fruits,
vegetables or unprocessed whole foods. Food insecurity is associated with the degree to
which diet influences immune-inflammatory pathways, which as previously mentioned,
may have an etiological role in the development of mood disorders, particularly MDD
(Bergmans et al., 2018).
The Physicians Committee for Responsible Medicine has proposed significant
changes in the current SNAP program (Supplemental Nutrition Assistance Program)
aimed at helping those lacking adequate access to healthier food choices. It is widely
believed that the cost of plant-based foods is too expensive; however, analyses are based
on cost per calorie without any consideration for nutritional value (Flynn & Schiff, 2015;
Springmann et al., 2016). There is no doubt that based on cost per calorie, caloricallydense foods high in saturated fat and sugar are cheaper. Although the current SNAP
program does very little to assure proper nutrition, the Physicians Committee for
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Responsible Medicine has suggested stores that accept SNAP payments should be
required to offer healthier foods, and they suggest that people can spend $1 on any food
of their choosing including junk food, or they can convert that $1 into $3 that can be used
to purchase fresh fruit and vegetables. It is clear that further effort is needed to make
plant-based diets more widely available to lower socioeconomic populations as adherence
to dietary advice has been shown to vary according to socioeconomic status.
Accepting that those experiencing food insecurity have less access to eat healthier
whole plant-based foods, we need to make the necessary changes in our food distribution
systems and government support agencies to partner with those who have less access to
healthy food options to assure that they too have the opportunity to gain an increased
sense of self-efficacy that comes when choosing foods that – rather than destroy our wellbeing – actually promote health and happiness. With several chronic, debilitating, and
functionally impairing diseases including CVD and MDD on the rise, we ought to think
about shifting our culture's outlook from “live to eat” to “eat to live.”
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FIGURES
Figure 1
5 Major Food Categories in a Whole Food, Plant-Based Diet
Food Category

Acceptable Foods

Fruit

mangoes, bananas, grapes, strawberries,
blueberries, oranges, cherries, etc.

Vegetables

lettuce, collard greens, broccoli,
cauliflower, kale, carrots, etc.

Tubers & Starchy Vegetables

potatoes, yams, yucca, winter squash,
corn, green peas, etc.

Whole Grains

millet, quinoa, barely, rice, whole wheat,
oats, etc.

Legumes

kidney beans, chickpeas, lentils, lima
beans, cannellini beans, black beans, etc.

Note. This figure shows the 5 major food categories allowed in a whole food, plant-based
diet along with examples from each. The foods listed above have all been demonstrated
to play a role in reducing inflammation.
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